DIP Database of Interacting Proteins 611 Young Drive East; Los Angeles CA 90095; USA http://dip.doe-mbi.ucla.edu/ dip@mbi.ucla.edu Platinum-based inhibitors of amyloid-beta as therapeutic agents for Alzheimer's disease. Platinum-based inhibitors of amyloid-beta as therapeutic agents for Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 2008 imex curation Barnham KJ., Kenche VB., Ciccotosto GD., Smith DP., Tew DJ., Liu X., Perez K., Cranston GA., Johanssen TJ., Volitakis I., Bush AI., Masters CL., White AR., Smith JP., Cherny RA., Cappai R., Barnham KJ., Kenche VB., Ciccotosto GD., Smith DP., Tew DJ., Liu X., Perez K., Cranston GA., Johanssen TJ., Volitakis I., Bush AI., Masters CL., White AR., Smith JP., Cherny RA., Cappai R. Alzheimers - Interactions investigated in the context of Alzheimers disease Only protein-protein interactions in vitro In vitro fluorescence spectr classical fluorescence spectroscopy fluorescence spectr predetermined predetermined participant predetermined Barnham KJ., Kenche VB., Ciccotosto GD., Smith DP., Tew DJ., Liu X., Perez K., Cranston GA., Johanssen TJ., Volitakis I., Bush AI., Masters CL., White AR., Smith JP., Cherny RA., Cappai R. Alzheimers - Interactions investigated in the context of Alzheimers disease DIP original experiment: DIP-110992X Proceedings of the National Academy of Sciences of the United States of America 2008 IMEx Platinum-based inhibitors of amyloid-beta as therapeutic agents for Alzheimer's disease. Platinum-based inhibitors of amyloid-beta as therapeutic agents for Alzheimer's disease. Platinum-based inhibitors of amyloid-beta as therapeutic agents for Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 2008 imex curation Barnham KJ., Kenche VB., Ciccotosto GD., Smith DP., Tew DJ., Liu X., Perez K., Cranston GA., Johanssen TJ., Volitakis I., Bush AI., Masters CL., White AR., Smith JP., Cherny RA., Cappai R., Barnham KJ., Kenche VB., Ciccotosto GD., Smith DP., Tew DJ., Liu X., Perez K., Cranston GA., Johanssen TJ., Volitakis I., Bush AI., Masters CL., White AR., Smith JP., Cherny RA., Cappai R. Alzheimers - Interactions investigated in the context of Alzheimers disease Only protein-protein interactions in vitro In vitro 3d-em 3D electron microscopy 3D-EM electron tomog predetermined predetermined participant predetermined Barnham KJ., Kenche VB., Ciccotosto GD., Smith DP., Tew DJ., Liu X., Perez K., Cranston GA., Johanssen TJ., Volitakis I., Bush AI., Masters CL., White AR., Smith JP., Cherny RA., Cappai R. Alzheimers - Interactions investigated in the context of Alzheimers disease DIP original experiment: DIP-110993X Proceedings of the National Academy of Sciences of the United States of America 2008 IMEx Platinum-based inhibitors of amyloid-beta as therapeutic agents for Alzheimer's disease. p05067-pro_0000000092 Amyloid-beta protein 42 Alzheimer disease amyloid protein Cerebral vascular amyloid peptide APP A4 AD1 ABPP PreA4 Protease nexin-II APPI Amyloid precursor protein Amyloid-beta A4 protein Alzheimer disease amyloid A4 protein homolog Amyloid-beta (A4) precursor protein protein protein human Homo sapiens Human DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA 672 713 3AC85563D7858C37 abeta142-1 1 3 unspecified role unspecified role unspecified role unspecified role in vitro In vitro 3 unspecified role unspecified role unspecified role unspecified role in vitro In vitro direct interaction direct interaction abeta142-2 2 3 unspecified role unspecified role unspecified role unspecified role in vitro In vitro 3 unspecified role unspecified role unspecified role unspecified role in vitro In vitro direct interaction direct interaction